drugset
drugset / Trial / NCT04729088

Pharmacokinetics Trial of Isosorbide Mononitrate 0.5% Gel for Intra Anal Application in Healthy Subjects

NCT04729088 ↗

Phase 1 Withdrawn Biolab Sanus Farmaceutica
NaSingle-groupOpen-labelOther

Summary

This is a Phase I trial to evaluate pharmacokinetics and safety of Isosorbide Mononitrate gel for intra anal administration in healthy subjects.

Timeline

Start
2020-12-20
Primary completion
2020-12-20
Completion
2020-12-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Isosorbide Mononitrate Other / unclassified 2 g Other

Indications

No indication recorded.